Schulz, E., Curtis, L. M., Holtzman, N. G., Steinberg, S. M., Wloka, K., Ostojic, A., Mina, A., Jurdi, N. E., Pirsl, F., Carpenter, A., Golagha, M., Sirajuddin, A., Heller, T., Shaffer, B. C., Hakim, F. T., Rubin, J. S., Gress, R. E., Pavletic, S. Z. (2025). Phase 1/2 study of high-dose palifermin for GVHD prophylaxis in patients undergoing HLA-matched unrelated donor HCT. Blood. https://doi.org/10.1182/blood.2024028303